REFERENCES
1. Reig M, Sanduzzi-Zamparelli M, Forner A, et al. BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update. J Hepatol. 2026;84:631-54.
2. Vitale A, Cabibbo G, Iavarone M, et al.; HCC Special Interest Group of the Italian Association for the Study of the Liver. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. Lancet Oncol. 2023;24:e312-22.
3. Vitale A, Brancaccio G, Miele L, et al.; HCC Special Interest Group of the Italian Association for the Study of the Liver (AISF). The multiparametric therapeutic hierarchy: a multidisciplinary approach to HCC management. Hepatoma Res. 2025;11:26.
4. Lai Q, Centonze L, Renzulli M, et al.; Group the Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest. Importance of critical tumor features in multidisciplinary multi-parametric assessment of HCC. Hepatoma Res. 2025;11:14.
5. Masarone M, Cabibbo G, Pravisani R, et al. ; the Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group. The importance of patient fitness in expert and multidisciplinary multiparametric management of HCC: a narrative review. Hepatoma Res. 2025;11:21.
6. Tovoli F, Crocetti L, Mazzarelli C, et al. ; on behalf of the AISF HCC Special Interest Group. Converse therapeutic hierarchy in hepatocellular carcinoma. Hepatoma Res. 2026;12:6.
7. Govoni I, Padoan V, Vitale A, et al. ; on behalf of the HCC Special Interest Group of the Italian Association for the Study of the Liver. The role of “treatment unfeasibility” in the multiparametric, multidisciplinary, and expert evaluation of HCC patients. Hepatoma Res. 2026;12:10.
8. Vitale A, Piscaglia F, Sangiovanni A, et al. ; ITA.LI.CA Study Group. The Yin-Yang of HCC management: reconciling therapeutic hierarchy and transplant benefit in real-world evidence. Liver Transpl. 2026;32:638-41.
9. Abdelhamed W, El-Kassas M. Integrating artificial intelligence into multidisciplinary evaluations of HCC: opportunities and challenges. Hepatoma Res. 2025;11:8.
